LNTH as reported
Lantheus Holdings, Inc. reported $1.55B of revenue over the trailing twelve months, +0.62% on the year before. 11 reported series are charted on this page, each one as filed.
$1.55B
Revenue, trailing twelve months · to Q1 2026 · +0.62% against the twelve months before
- Net Income
- $279M
Net Income · +9.7% year on year · trailing twelve months to Q1 2026
- Free Cash Flow
- $377M
Free Cash Flow · −20% year on year · trailing twelve months to Q1 2026
- Op Margin
- 19%
Op Margin · trailing twelve months to Q1 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.55B | +0.62% | Q1 2026 |
| Net Income | $279M | +9.7% | Q1 2026 |
| EPS | $4.14 | +18% | Q1 2026 |
| Gross Margin | 61% | n/a | Q1 2026 |
| Op Margin | 19% | n/a | Q1 2026 |
| Net Margin | 18% | n/a | Q1 2026 |
| ROE | 21% | n/a | Q1 2026 |
| ROA | 11% | n/a | Q1 2026 |
| ROIC | 23% | n/a | Q1 2026 |
| Free Cash Flow | $377M | −20% | Q1 2026 |
| P/E | 24.4 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Lantheus Holdings, Inc. (LNTH) - Revenue & ProfitRevenue & ProfitLantheus Holdings, Inc. (LNTH)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Drug Manufacturers - Specialty & Generic
Ranks #25 of 28 by Smart Score